<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>Acute asthma (adult) — DGRefHelp Drafts</title>
  <link rel="stylesheet" href="../assets/site.css" />
</head>
<body>
  <div class="container">
    <div class="header">
      <div class="brand">
        <h1><a href="../index.html">DGRefHelp drafts</a> / Acute asthma (adult)</h1>
        <div class="sub">Time-critical triage: measure severity (speech/respiratory distress + PEF + SpO2), give inhaled SABA promptly, start steroids early, and escalate urgently for severe/life-threatening features.</div>
      </div>
      <div class="badges">
        <div class="badge">Mode: quick</div>
        <div class="badge">Last updated: 2026‑02‑10</div>
      </div>
    </div>

    <div class="grid">
      <div class="card">
        <div class="card-hd">
          <div class="tabs" data-tabs>
            <button class="tab" role="tab" data-tab="evidence" aria-selected="true">Evidence</button>
            <button class="tab" role="tab" data-tab="draft" aria-selected="false">DGRefHelp draft</button>
            <button class="tab" role="tab" data-tab="refs" aria-selected="false">References</button>
          </div>
          <div class="copybar">
            <button class="btn" data-copy-target="#draftText">Copy draft</button>
            <button class="btn" data-copy-target="#evidenceText">Copy evidence</button>
          </div>
        </div>

        <div class="card-bd">
          <div class="panel active" role="tabpanel" data-panel="evidence">
            <div id="evidenceText" class="section">
              <h3>Evidence summary (triangulated)</h3>

              <div class="callout ok">
                <strong>Key design points (BTS/SIGN-aligned)</strong>
                <ul>
                  <li>Acute asthma severity assessment should not rely on wheeze: a <strong>silent chest</strong>, exhaustion or altered consciousness are high-risk signs.</li>
                  <li>Use a <strong>structured severity classification</strong> (moderate / acute severe / life-threatening / near-fatal) based on clinical features + <strong>PEF</strong> and <strong>SpO2</strong>.</li>
                  <li>Give <strong>high-dose inhaled SABA promptly</strong> (via MDI + spacer where possible); start <strong>oral corticosteroids early</strong> in acute attacks.</li>
                  <li>Patients with <strong>acute severe or life-threatening features</strong> generally need <strong>same-day ED/acute assessment</strong> (and many will need nebulised therapy, oxygen, IV therapy and/or ABGs).</li>
                  <li>Oxygen: use a <strong>target saturation approach</strong> (asthma usually targets 94–98%) and escalate if deteriorating.</li>
                </ul>
              </div>

              <div class="callout warn">
                <strong>Localisation needed</strong>
                <ul>
                  <li>How primary care accesses <strong>nebulisers, oxygen, peak-flow meters</strong> and emergency drugs varies — keep the local operational pathway explicit.</li>
                  <li>SDEC / rapid-access respiratory services and ambulance thresholds are local; this draft uses standard BTS/SIGN severity triggers as a default.</li>
                </ul>
              </div>

              <h4>Comparator sources used for the draft</h4>
              <ul>
                <li>BTS/SIGN. <em>British guideline on the management of asthma</em> (SIGN 158) — acute asthma: severity classification and emergency management principles.</li>
                <li>British Thoracic Society. <em>Emergency Oxygen</em> — oxygen targets and safe prescribing/monitoring principles.</li>
              </ul>

              <p class="small">Draft note: This is a DGRefHelp-style triage + documentation scaffold for adult acute asthma. Drug doses and local emergency kit contents should be checked against local policy/formulary.</p>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="draft">
            <div id="draftText" class="section">
              <h3>Acute asthma (adult) — primary care / out-of-hospital</h3>

              <h4>Definition / scope</h4>
              <ul>
                <li>Acute worsening of asthma symptoms (wheeze, breathlessness, chest tightness, cough) requiring additional reliever therapy.</li>
                <li>This page is for <strong>adults</strong>. (Children/pregnancy: use age-/setting-specific guidance.)</li>
                <li>Always consider differentials, especially if atypical: anaphylaxis, pneumonia, pneumothorax, PE, heart failure, upper airway obstruction / inducible laryngeal obstruction.</li>
              </ul>

              <h4>Immediate red flags (call 999 / ED)</h4>
              <ul>
                <li><strong>Life-threatening features</strong> (any):
                  <ul>
                    <li>Unable to speak, confusion/drowsiness, collapse, exhaustion, cyanosis.</li>
                    <li><strong>Silent chest</strong> / very poor respiratory effort.</li>
                    <li><strong>SpO2 &lt;92%</strong> (or falling despite treatment).</li>
                    <li><strong>PEF &lt;33%</strong> of best/predicted (if measurable).</li>
                  </ul>
                </li>
                <li><strong>Acute severe asthma features</strong> (treat + same-day ED assessment):
                  <ul>
                    <li>PEF <strong>33–50%</strong> of best/predicted.</li>
                    <li>RR <strong>≥25/min</strong> or HR <strong>≥110/min</strong>.</li>
                    <li>Unable to complete sentences in one breath.</li>
                  </ul>
                </li>
                <li><strong>Near-fatal asthma</strong> is suspected if rising CO2 / respiratory failure is likely (typically requires ABGs and critical care level assessment).</li>
              </ul>

              <h4>Assessment (do quickly; repeat after treatment)</h4>
              <ul>
                <li><strong>Observations:</strong> RR, HR, BP, Temp, <strong>SpO2</strong>; mental state; work of breathing; ability to speak.</li>
                <li><strong>Peak expiratory flow (PEF):</strong> record best of 3 if feasible; compare to personal best or predicted; document %.</li>
                <li><strong>History:</strong> previous ICU/ventilation/near-fatal attack; current inhalers and adherence; recent oral steroids; triggers (viral, allergen, NSAIDs); smoking/vaping; comorbid COPD; pregnancy (if relevant).</li>
                <li><strong>Look for alternate diagnosis:</strong> chest pain/pleurisy, fever, unilateral reduced air entry, signs of anaphylaxis (urticaria, angioedema, hypotension), calf pain/haemoptysis.</li>
              </ul>

              <h4>Immediate treatment (primary care / out-of-hospital)</h4>
              <ul>
                <li><strong>High-dose inhaled SABA:</strong> give promptly.
                  <ul>
                    <li>Preferred: <strong>salbutamol MDI + spacer</strong> (repeated doses as per local emergency protocol).</li>
                    <li>If severe and MDI/spacer not feasible: <strong>nebulised salbutamol</strong> (if available) while awaiting ambulance.</li>
                  </ul>
                </li>
                <li><strong>Oral corticosteroid early:</strong> if acute attack needing reliever escalation or any severe features — typical adult dosing is prednisolone <strong>40–50 mg</strong> daily for <strong>5 days</strong> (local protocol/formulary).</li>
                <li><strong>Oxygen (if available):</strong> target <strong>SpO2 94–98%</strong>. Escalate urgently if hypoxic or deteriorating.</li>
                <li><strong>Add ipratropium</strong> (usually nebulised) for acute severe/life-threatening asthma if available locally and awaiting transfer.</li>
                <li><strong>Antibiotics:</strong> not routine for asthma attacks; consider only if clear evidence of bacterial infection.</li>
              </ul>

              <h4>Disposition</h4>
              <ul>
                <li><strong>ED / acute medical assessment:</strong> any acute severe or life-threatening features; poor response to initial bronchodilator; recurrent symptoms soon after treatment; significant comorbidity/frailty; social concerns or inability to self-manage.</li>
                <li><strong>Consider home management</strong> only if clearly <strong>mild/moderate</strong>, improves quickly with inhaled SABA, observations stable (including SpO2), and there is a reliable plan for follow-up and escalation.</li>
              </ul>

              <h4>Aftercare if managed in the community</h4>
              <ul>
                <li><strong>Review within 24–48 hours</strong> (earlier if any concern).</li>
                <li>Check inhaler technique and adherence; ensure an <strong>asthma action plan</strong>.</li>
                <li>Optimise preventer therapy and arrange routine asthma review (consider MART/ICS-formoterol strategy if used locally).</li>
                <li>Safety-net: worsening breathlessness, reduced speech, fainting, blue lips, SpO2 falling, or needing reliever more frequently than every 4 hours → seek urgent help / call 999.</li>
              </ul>

              <h4>Referral letter / triage metrics (if referring)</h4>
              <ul>
                <li>Severity classification (moderate / acute severe / life-threatening) and what features are present.</li>
                <li>Observations (RR/HR/BP/Temp/SpO2) and mental state.</li>
                <li>PEF: absolute value + % best/predicted, and response to treatment.</li>
                <li>Treatments given + times (SABA doses/route; ipratropium; oxygen; steroid dose/time).</li>
                <li>Past risk history: ICU/ventilation, previous near-fatal attack, recent oral steroids, previous admissions.</li>
                <li>Trigger/differential concerns (anaphylaxis, pneumonia, pneumothorax, PE).</li>
              </ul>

              <div class="callout warn">
                <strong>Local agreement needed (D&amp;G)</strong>
                <ul>
                  <li>[ ] Confirm local adult acute asthma emergency protocol for primary care/out-of-hours (SABA dosing strategy; when to add ipratropium; ambulance triggers).</li>
                  <li>[ ] Confirm local availability and policy for oxygen + nebulisers in community settings (and who can administer/monitor).</li>
                  <li>[ ] Agree local post-attack follow-up expectation (24–48h review; preventer optimisation; action plan template).</li>
                  <li>[ ] Confirm whether SDEC/respiratory rapid-access is available/appropriate for improving patients vs default ED assessment.</li>
                </ul>
              </div>
            </div>
          </div>

          <div class="panel" role="tabpanel" data-panel="refs">
            <div class="section">
              <h3>References</h3>
              <ul>
                <li>SIGN/BTS. <em>British guideline on the management of asthma (SIGN 158)</em>. Updated version (acute asthma sections used). Accessed 2026‑02‑10. https://www.sign.ac.uk/guidelines/british-guideline-on-the-management-of-asthma/</li>
                <li>British Thoracic Society. <em>Emergency Oxygen</em> (guideline resources). Accessed 2026‑02‑10. https://www.brit-thoracic.org.uk/quality-improvement/guidelines/emergency-oxygen/</li>
              </ul>
              <p class="small">Draft note: doses are provided as typical UK adult defaults; check local D&amp;G protocols/formulary for exact emergency kit content and dosing, and update the localisation checklist accordingly.</p>
            </div>
          </div>

        </div>
      </div>
    </div>
  </div>

  <script src="../assets/site.js"></script>
</body>
</html>
